Supernus' 4th try proves the charm with long-awaited FDA approval for Parkinson's infusion pump Onapgo

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump.

On its fourth attempt to pass muster with the FDA, the company’s SPN-830, now branded as Onapgo, finally earned the agency’s stamp of approval to treat motor fluctuations in adults with advanced Parkinson’s.